Fintech stocks have been in a rut since 2021. That may be about to change.
Morgan Stanley’s Jonas downgrades Ford and GM, citing China competition, problems with U.S. consumer
The outlook for the U.S. auto industry is getting worse, which could put pressure on Ford Motor and General Motors, according to Morgan Stanley’s Adam Jonas.
Wednesday’s analyst calls: Tesla price target hike, Hewlett Packard Enterprise upgraded
An electric vehicle maker and an enterprise tech name were among the stocks being talked about by analysts on Wednesday.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
Stocks extended their rally on Tuesday, with the Dow and the S&P 500 hitting new records. Here’s what CNBC is watching going into Wednesday.
Meet the Latin American e-commerce platform that’s outperforming Amazon this year
MercadoLibre has emerged as a top pick on Wall Street as investors search for tech opportunities beyond the Magnificent Seven.
These funds aim to multiply the market’s dividend yield. How they stack up to competitors
Pacer launched a new exchange traded fund on Tuesday designed to deliver distributions six times greater than the dividend yield on the Nasdaq-100 Index.
A popular China ETF is surging Tuesday. It’s not time to jump in just yet, according to the charts
Frank Cappelleri breaks down the charts in the iShares China Large Cap ETF (FXI).
Is Ozempic to blame for the slowdown in salty snack sales? Here’s the verdict
Investors who worry that rising GLP-1 drug usage has impaired salty snack sales might be pointing the finger at the wrong culprit.
Here’s how Apple might cash in on its latest artificial intelligence features
Wall Street weighs in on whether Apple Intelligence could benefit as a paid tool.
Goldman sees this biotech fighting rare diseases rallying 35%
The bank initiated coverage at a buy rating.